Search research articles
Contact Us
Filters
Showing results (101-110 of 166) with videos related to
Page
of 17
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 1, 1994
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)
N R Cutler, J J Sramek, A E Macpherson, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial
N R Cutler, J J Sramek, J M Keppel Hesselink, et al.
Annals of Neurology
|
April 1, 1987
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome
A D Kay, M B Schapiro, A K Riker, et al.
Journal of Clinical Psychopharmacology
|
October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophrenia
J J Sramek, R J Mack, W Awni, et al.
Life Sciences
|
January 1, 1995
A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's disease
J J Sramek, C Viereck, F J Huff, et al.
Archives of Neurology
|
October 1, 1986
Cerebrospinal fluid biopterin is decreased in Alzheimer's disease
A D Kay, S Milstien, S Kaufman, et al.
Cephalalgia : an International Journal of Headache
|
April 24, 1999
A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension
S S Jhee, D E Salazar, N F Ford, et al.
Decubitus
|
November 1, 1993
Comparison of quantitative methodologies to define chronic pressure ulcer measurements
N R Cutler, R George, R D Seifert, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatients
N R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease
J V Gobburu, V Tammara, L Lesko, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 166) with videos related to
Sort By:
Page
of 17
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 1, 1994
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)
N R Cutler, J J Sramek, A E Macpherson, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial
N R Cutler, J J Sramek, J M Keppel Hesselink, et al.
Annals of Neurology
|
April 1, 1987
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome
A D Kay, M B Schapiro, A K Riker, et al.
Journal of Clinical Psychopharmacology
|
October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophrenia
J J Sramek, R J Mack, W Awni, et al.
Life Sciences
|
January 1, 1995
A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer's disease
J J Sramek, C Viereck, F J Huff, et al.
Archives of Neurology
|
October 1, 1986
Cerebrospinal fluid biopterin is decreased in Alzheimer's disease
A D Kay, S Milstien, S Kaufman, et al.
Cephalalgia : an International Journal of Headache
|
April 24, 1999
A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension
S S Jhee, D E Salazar, N F Ford, et al.
Decubitus
|
November 1, 1993
Comparison of quantitative methodologies to define chronic pressure ulcer measurements
N R Cutler, R George, R D Seifert, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatients
N R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease
J V Gobburu, V Tammara, L Lesko, et al.
Page
of 17